The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]


Variant: NM_000018.4(ACADVL):c.1534_1535del (p.Arg512fs)

CA1139665155

932831 (ClinVar)

Gene: ACADVL
Condition: very long chain acyl-CoA dehydrogenase deficiency
Inheritance Mode: Autosomal recessive inheritance
UUID: 94366174-ad31-4af9-81c2-8fff20ad99b3

HGVS expressions

NM_000018.4:c.1534_1535del
NM_000018.4(ACADVL):c.1534_1535del (p.Arg512fs)
NC_000017.11:g.7224322_7224323del
CM000679.2:g.7224322_7224323del
NC_000017.10:g.7127641_7127642del
CM000679.1:g.7127641_7127642del
NC_000017.9:g.7068365_7068366del
NG_007975.1:g.9489_9490del
NG_008391.2:g.729_730del
NG_033038.1:g.15223_15224del
ENST00000356839.10:c.1534_1535del
ENST00000322910.9:c.*1489_*1490del
ENST00000350303.9:c.1468_1469del
ENST00000356839.9:c.1534_1535del
ENST00000542255.6:n.392_393del
ENST00000543245.6:c.1603_1604del
ENST00000578319.5:n.29_30del
ENST00000578711.1:n.818_819del
ENST00000578809.5:n.106_107del
ENST00000579391.1:n.142_143del
ENST00000579425.5:n.650_651del
ENST00000579546.1:n.273_274del
ENST00000579894.5:n.321_322del
ENST00000582450.1:n.42_43del
ENST00000583074.5:n.155_156del
ENST00000583850.5:n.309_310del
ENST00000583858.5:n.465_466del
ENST00000585203.6:n.725_726del
NM_000018.3:c.1534_1535del
NM_001033859.2:c.1468_1469del
NM_001270447.1:c.1603_1604del
NM_001270448.1:c.1306_1307del
NM_001033859.3:c.1468_1469del
NM_001270447.2:c.1603_1604del
NM_001270448.2:c.1306_1307del

Likely Pathogenic

Met criteria codes 2
PVS1 PM2_Supporting

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen ACADVL Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines Version 1

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
ACADVL VCEP
The c.1534_1535del (p.Arg512GlyfsTer49) variant in ACADVL is a frameshift variant predicted to cause a premature stop codon in biologically-relevant-exon 17/20 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1; PMIDs: 9973285, 11590124). This variant is absent from gnomAD 2.1.1 (PM2_Supporting). To our knowledge, functional assays have not been reported for this variant. To our knowledge, this variant has not been reported in the literature in any individuals with VLCADD. . In summary, this variant meets the criteria to be classified as LIKELY PATHOGENIC for autosomal recessive very long chain acyl-CoA dehydrogenase (VLCAD) deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen ACADVL Variant Curation Expert Panel: PVS1, PM2_Supporting (ClinGen ACADVL VCEP specifications version#1.0; approved 12-29-22).
Met criteria codes
PVS1
PVS1 is met. The c.1534_1535del (p.Arg512GlyfsTer49) variant in ACADVL is a frameshift variant predicted to cause a premature stop codon in biologically-relevant-exon 17/20 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1; PMIDs: 9973285, 11590124).
PM2_Supporting
PM2_Supporting is met. This variant is absent from gnomAD 2.1.1 (PM2_Supporting).
Approved on: 2023-06-29
Published on: 2023-06-29
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.